Analytical Data
-
Gene name
ITFG1
- Application
-
Alternative Names
CDA08; TIP; T Cell Immunomodulatory Protein
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8TB96
-
Expression Region
Asp55~Asp306
-
Molecular Weight
32kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ITFG1, or Intermediate TGF-beta Fujin-Gene 1, is a protein that plays a significant role in various cellular processes, including signal transduction, cell growth, and differentiation. Research into ITFG1 has gained importance due to its potential implications in cancer biology, immune response, and developmental processes. Studies have suggested that dysregulation of ITFG1 may contribute to tumorigenesis and affect the progression of certain diseases, including autoimmune disorders. The characterization of ITFG1, particularly its structure and interactions with other proteins, is essential for understanding its biological functions and pathways. Recent advances in recombinant protein technology have enabled researchers to produce ITFG1 in vitro, facilitating detailed investigations into its functional properties. By understanding the molecular mechanisms underlying ITFG1's activity, scientists aim to identify potential therapeutic targets and develop novel treatment strategies for diseases associated with its dysfunction. This research is crucial for advancing our knowledge of cellular signaling networks and their roles in health and disease.
